Long-term efficacy and safety of CT-P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Nam Hee | - |
dc.contributor.author | Park, Dong Il | - |
dc.contributor.author | Kim, You Sun | - |
dc.contributor.author | Eun, Chang Soo | - |
dc.contributor.author | Cha, Jae Myung | - |
dc.contributor.author | Hong, Sung Noh | - |
dc.contributor.author | Jang, Byung Ik | - |
dc.contributor.author | Kim, Ji Won | - |
dc.contributor.author | Kim, Duk Hwan | - |
dc.contributor.author | Kang, Hyoun Woo | - |
dc.contributor.author | Choi, Chang Hwan | - |
dc.contributor.author | Kim, Eun Sun | - |
dc.contributor.author | Im, Jong Pil | - |
dc.contributor.author | Yoon, Hyuk | - |
dc.date.available | 2021-01-14T04:40:26Z | - |
dc.date.issued | 201811 | - |
dc.identifier.issn | 0815-9319 | - |
dc.identifier.issn | 1440-1746 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/47487 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | Long-term efficacy and safety of CT-P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study | - |
dc.type | Conference | - |
dc.identifier.doi | 10.1111/jgh.14488 | - |
dc.citation.title | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | - |
dc.citation.startPage | 479 | - |
dc.citation.endPage | 479 | - |
dc.citation.conferenceName | Asian Pacific Digestive Week (APDW) 2018 | - |
dc.citation.conferencePlace | 미국 | - |
dc.citation.conferencePlace | Seoul, Korea | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.